The prospectus or the TMT analytics research report has alot of SMX's technology and competition.
DDT ADNAS YPB etc do not have comparable proprietary technology as compared to SMX
"Why has the company not gained traction in Israel in the years before taking it public?"
SMX hasn't been around for years and the technology has only been negotiated to commercialise from Israels Soreqs nuclear research program over the last year before going public on the ASX. Prior to listing, they have been working on commercialisation efforts of which these efforts are now being realised.
SMX Price at posting:
61.0¢ Sentiment: Buy Disclosure: Held